CHLORHEXIDINE GLUCONATE ORAL RINSE

CHLORHEXIDINE GLUCONATE ORAL RINSE was reported 84 times

CHLORHEXIDINE GLUCONATE ORAL RINSE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CITROBACTER TEST POSITIVE 1 0.0152
1 URTICARIA THERMAL 2 0.0141
2 BURKHOLDERIA TEST POSITIVE 1 0.0081
3 EJECTION FRACTION 2 0.0034
4 MUSCLE INJURY 28 0.0034
5 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 21 0.0032
6 FOLLICULITIS 28 0.0027
7 MUSCLE SPASTICITY 21 0.0017
8 KLEBSIELLA TEST POSITIVE 1 0.0015
9 IRRITABLE BOWEL SYNDROME 28 0.0013
10 PULMONARY ARTERY THROMBOSIS 1 0.0013
11 SPUTUM CULTURE POSITIVE 1 0.0012
12 EAR PAIN 21 0.0011
13 BODY TEMPERATURE INCREASED 22 0.0011
14 LOWER RESPIRATORY TRACT INFECTION 46 0.0010
15 CONTRAINDICATED PRODUCT ADMINISTERED 27 0.0009
16 IMPAIRED HEALING 27 0.0008
17 LIP DISCOLOURATION 1 0.0008
18 ECHOCARDIOGRAM ABNORMAL 1 0.0007
19 RESPIRATORY DISORDER 21 0.0007
20 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5 0.0007
21 DUODENAL ULCER PERFORATION 5 0.0007
22 NIGHT SWEATS 21 0.0007
23 PREMATURE DELIVERY 10 0.0006
24 THERAPEUTIC PRODUCT EFFECT DECREASED 28 0.0006
25 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
26 WOUND SECRETION 2 0.0005
27 BLISTER 28 0.0005
28 HELICOBACTER INFECTION 5 0.0005
29 ATRIAL THROMBOSIS 1 0.0005
30 ILL-DEFINED DISORDER 29 0.0005
31 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
32 SINUSITIS 47 0.0005
33 STOMATITIS 27 0.0004
34 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
35 PEMPHIGUS 5 0.0004
36 JOINT SWELLING 48 0.0004
37 BLOOD PRESSURE DIASTOLIC ABNORMAL 1 0.0004
38 HAND DEFORMITY 5 0.0004
39 SENSITIVITY TO WEATHER CHANGE 2 0.0004
40 ASTHENOPIA 2 0.0004
41 TOOTH DISCOLOURATION 1 0.0003
42 PREMATURE BABY 10 0.0003
43 PERIPHERAL SWELLING 50 0.0003
44 GASTROINTESTINAL DISORDER 28 0.0003
45 PERICARDITIS 5 0.0003
46 METASTASES TO LYMPH NODES 2 0.0003
47 PRODUCT CONTAMINATION 1 0.0003
48 SWELLING 26 0.0003
49 GLOSSODYNIA 5 0.0002
50 SYNOVITIS 4 0.0002
51 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
52 PRODUCT COLOUR ISSUE 1 0.0002
53 INFECTION 28 0.0002
54 CONTUSION 17 0.0002
55 NASOPHARYNGITIS 31 0.0002
56 HYPERSENSITIVITY 30 0.0002
57 CORONAVIRUS INFECTION 1 0.0002
58 WOUND 4 0.0001
59 URTICARIA 23 0.0001
60 PRURITUS 52 0.0001
61 PULMONARY MASS 2 0.0001
62 CONFUSIONAL STATE 21 0.0001
63 WEIGHT INCREASED 29 0.0001
64 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
65 METASTASES TO BONE 2 0.0001
66 INFUSION RELATED REACTION 8 0.0001
67 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
68 DISCOMFORT 7 0.0001
69 RASH 50 0.0001
70 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
71 RECALLED PRODUCT ADMINISTERED 1 0.0001
72 HEPATIC ENZYME INCREASED 7 0.0001
73 ABDOMINAL PAIN UPPER 21 0.0001
74 OVARIAN CYST 1 0.0001
75 PREGNANCY 2 0.0001
76 FOETAL EXPOSURE DURING PREGNANCY 8 0.0001
77 DERMATITIS 2 0.0001
78 INSOMNIA 25 0.0001
79 ASPIRATION 1 0.0001
80 BACK PAIN 21 0.0001
81 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
82 ARTHROPATHY 5 0.0001
83 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
84 SKIN INFECTION 1 0.0001
85 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
86 PYREXIA 27 0.0001
87 PAIN OF SKIN 2 0.0001
88 SKIN LESION 2 0.0001
89 ORAL DISCOMFORT 1 0.0001
90 SLEEP DISORDER 5 0.0001
91 SEASONAL ALLERGY 1 0.0001
92 PAIN 42 0.0001
93 ARTHRALGIA 28 0.0001
94 STAPHYLOCOCCAL INFECTION 2 0.0001
95 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
96 SCAR 1 0.0001
97 ASTHENIA 21 0.0001
98 DYSPNOEA 30 0.0001
99 DRUG INTOLERANCE 5 0.0001
100 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
101 VOMITING 21 0.0000
102 PULMONARY OEDEMA 2 0.0000
103 RHEUMATOID ARTHRITIS 5 0.0000
104 SKIN DISCOLOURATION 2 0.0000
105 AGGRESSION 2 0.0000
106 HOT FLUSH 3 0.0000
107 FATIGUE 30 0.0000
108 ECZEMA 2 0.0000
109 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
110 MENSTRUATION IRREGULAR 1 0.0000
111 OEDEMA 2 0.0000
112 ANAPHYLACTIC REACTION 2 0.0000
113 HEADACHE 22 0.0000
114 IRRITABILITY 2 0.0000
115 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
116 DIARRHOEA 21 0.0000
117 LIP SWELLING 1 0.0000
118 ABDOMINAL DISCOMFORT 5 0.0000
119 HEART RATE DECREASED 1 0.0000
120 MOBILITY DECREASED 2 0.0000
121 EPISTAXIS 2 0.0000
122 ALOPECIA 5 0.0000
123 DRUG INEFFECTIVE 31 0.0000
124 ANGIOEDEMA 1 0.0000
125 FLUSHING 2 0.0000
126 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
127 ERYTHEMA 4 0.0000
128 OFF LABEL USE 17 0.0000
129 ABDOMINAL DISTENSION 2 0.0000
130 HERPES ZOSTER 1 0.0000
131 EMOTIONAL DISTRESS 2 0.0000
132 PLEURAL EFFUSION 1 0.0000
133 DRY SKIN 2 0.0000
134 PRODUCT QUALITY ISSUE 2 0.0000
135 BLOOD PRESSURE INCREASED 2 0.0000
136 CARDIAC FAILURE 1 0.0000
137 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
138 PRODUCT USE ISSUE 2 0.0000
139 PULMONARY EMBOLISM 1 0.0000
140 CHEST DISCOMFORT 1 0.0000
141 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
142 ANXIETY 2 0.0000
143 MALAISE 3 0.0000
144 PNEUMONIA 2 0.0000
145 SOMNOLENCE 1 0.0000
146 DEPRESSION 1 0.0000
147 ABDOMINAL PAIN 1 0.0000
148 NAUSEA 3 0.0000
149 WEIGHT DECREASED 1 0.0000
150 DEATH 1 0.0000